The view that menopause is a disease is dominant in Westernized societies, where menopause has long been considered an estrogen deficiency disease and, more recently, an endocrinopathy. The definition of menopause as disease has its origins in patriarchal views and beliefs about women as defective and imperfect, likened to machines that continually need to be fixed. This view of menopause has overshadowed the concept of menopause as a normal biological event, resulting in increased pressure to prescribe steroid sex hormones and perform surgical interventions on healthy women to prevent disease. Institutionalization of the "menopause as disease" ideology has legitimated, and thus condoned, the use of risk/benefit criteria normally used to assess risks versus harms in sick people. The use of these criteria assumes that acceptable risks for the sick are acceptable risks for healthy, well women.
Get full access to this article
View all access options for this article.
References
1.
Aumann, G.M.E. , & Meisell, A. (1993). Commentary on ethical issues of informed consent. Women's Health Issues, 3, 34-36.
Beit-Hallahmi, B. (1985). Dangers of the vagina. British Journal of Medical Psychology, 58, 351-356.
4.
Bernhard, L. (1992). Men's views about hysterectomies and women who have them. Image, 24, 177-181.
5.
Boring, C. C. , Squires, T. S., & Tong, T. (1993). Cancer statistics,
6.
Bush, T. L. , & Helzlsouer, K. J. (1993). Tamoxifen for the primary prevention of breast cancer: A review and critique of the concept and trial. Epidemiologic Reviews, 15, 233-242.
7.
Cobb, J. O. (1993). The 7th Congress of the International Menopause Society. A Friend Indeed, X, 1-4.
8.
Coffey, N. (1993). An introduction to hysterectomy, the operation and its lifelong consequences. HERS Newsletter, V, 2-4.
9.
Cohen, S. M. , & Linenberger, H. (1993, June). The lived experience of hysterectomy-A phenomenological study. Paper presented at the meeting of the Society for Menstrual Cycle Research, Boston, MA.
10.
Cutler, W. B. (1988). Hysterectomy before and after. New York: Harper & Row.
11.
Dahmoush, L. , Pike, M., & Press, M. F (1994). Hormones and breast-cell proliferation. In R. A. Lobo (Ed.), Treatment of the postmenopausal woman: Basic and clinical aspects (pp. 325-337). New York: Raven.
12.
Dorland, W. A. (1988). Dorland's illustrated medical dictionary. Philadelphia: W. B. Saunders.
13.
Franklin, P. (1991). Too many hysterectomies. New Directions for Women, 20, 8-8.
14.
Fraser, I. S. , McCarron, G., Markham, R., & Resta, T. (1985). Blood and total fluid content of menstrual discharge. Obstetrics and Gynecology, 65, 194-198.
15.
Gelfand, M. , Ferenczy, A., & Bergeron, C. (1989). Endometrial response to estrogen-androgen stimulation. In C. B. Hammond, F I. Haseltine, & I. Schiff (Eds.), Menopause: Evaluation, treatment and health concerns (pp. 29-40). New York: Alan R. Liss.
16.
Graves, E. J. (1989). Summary: National hospital discharge survey. (Advance data from vital and health statistics, Report No. 199). Hyattsville, MD: National Center for Health Statistics.
17.
Hatcher, R. A. , Stewart, F., Trussell, J., Kowal, D., Guest, F., Stewart, G. K., & Cates, W. (1990). Contraceptive technology 1990-1992. New York: Irvington.
18.
Hindle, W. H. (1993, September). Menopause, breast, and hormone replacement therapy. Paper presented at the meeting of the North American Menopause Society, San Diego, CA.
19.
Hufnagel, V. , & Golant, S. (1988). No more hysterectomies. New York: New American Library.
20.
Kaunitz, A. M. , & Darroch-Forrest, J. (1991). The second transition. Health and Sexuality, 2, 1-10.
21.
Lange, L. (1983). Woman is not a rational animal: On Aristotle's "Biology of Reproduction." In S. Harding & M. B. Hintikka (Eds.), Discovering reality (pp. 1-15). Dordrecht, Holland: D. Reidel.
22.
Mack, T. , Pike, M., Henderson, B., Pfeffer, R., Gerkins, V., Arthur, M., & Braun, S. (1976). Estrogens and endometrial cancer in a retirement community. New England Journal of Medicine, 294, 1262-1267.
23.
MacPherson, K. I. (1981). Menopause as disease: The social construction of a metaphor. Advances in Nursing Science, 3, 95-113.
24.
MacPherson, K. I. (1991). Hormone replacement therapy for menopause: A contrast between medical and women's health movement perspectives. In A. M. Voda & R. Conover (Eds.), Proceedings of the 8th conference Society for Menstrual Cycle Research. Salt Lake City, UT: Society for Menstrual Cycle Research.
25.
Malesky, G. , & Inlander, C. B. (1991). Take this book to the gynecologist with you: A consumers guide to women's health. New York: Addison-Wesley.
26.
Martin, E. (1986). Medical metaphors of women's bodies: Menstruation and menopause. International Journal of Health Services, 18, 237-254.
27.
Mendelsohn, R. S. (1981). Male practice. Chicago: Contemporary Books.
28.
National Breast Cancer Coalition . (1993). Breast cancerstatistics, 1993 (brochure). Washington, DC: Author.
29.
National Women's Health Network (1993). Taking hormones and women 's health: Choices, risks and benefits. Washington, DC: Author.
30.
Pavlides, N. A. , Petris, C., Briassoulis, E., Klouvas, G., Psilas, C., Rempapis, J., & Petroutsos, G. (1992). Clear evidence that long-term, low dose tamoxifen treatment can induce ocular toxicity. Cancer, 69, 2961-2964.
31.
Pearson, C. (1994, March/April). NCI warns women on tamoxifen of risk of fatal uterine cancer; changes in prevention trial consent form too little, too late. Network News, pp. 4-5.
32.
Pletnikoff, L. A. (1991). Seasonality of menarche in a population of native Alaskan women. Unpublished master's thesis, University of Alaska, Anchorage, AK.
33.
Pokras, R. , & Hufnagel, V. G. (1987). Hysterectomies in the United States 1965-1984 (DHHS Publication No. DHS 88-1753). Hyattsville, MD: National Center for Health Statistics.
34.
Ron, I. G. , Inbar, M. J., Borak, Y., Steir, S., & Chaitchik, S. (1992). Organic delusional syndrome associated with tamoxifen treatment. Cancer, 69, 1415-1417.
35.
Russo, J. , & Russo, I. H. (1987). Biological and molecular bases of mammary carcinogenesis. Laboratory Investigation, 57, 112-137.
36.
Schenken, R. S. , & Pauerstein, C. J. (1989). Effects of progestogens on the endometrium. In C. B. Hammond, F. I. Haseltine, & I. Schiff (Eds.), Menopause: Evaluation, treatment, and health concerns (pp. 1-28). New York: Alan R. Liss.
37.
Sheehy, G. (1992). The silent passage, menopause. New York: Random House.
38.
Smith, D. C. , Prentice, R., Thompson, D. J., & Herman, W. L. (1975). Association of exogenous estrogen and endometrial carcinoma among users of conjugated estrogens. New England Journal of Medicine, 293, 1167-1170.
39.
Smith, S. (1990). Historical perspective on menorrhagia. Antifibrinolytic therapy in dysfunctional uterine bleeding (pp. 2-3). Sweden: Kabi Pharmacia.
40.
Utian, W. H. (1990). The menopause in perspective. Annals of the New York Academy of Sciences, 592, 1-7.
41.
Utian, W. H. (1993, September). North American Menopause Society/Gallup survey of women's attitudes about menopause. Paper presented at the meeting of the North American Menopause Society, San Diego, CA.
42.
Voda, A. M. (1981). Alterations of the menstrual cycle: Hormonal and mechanical. In P. Komnenich, M. E. McSweeney, J. A. Noak, and N. Elder (Eds.), The menstrual cycle (Vol. 2). New York: Springer.
43.
Voda, A. M. (1992). Menopause: A normal view. Clinical Obstetrics and Gynecology, 35, 923-934.
44.
Voda, A. M. (1993). Journey to the center of the cell. In J. Callahan (Ed.), Menopause: A midlife passage (pp. 160-193). Bloomington: University of Indiana Press.
45.
Voda, A. M. , & George, T. (1986). Menopause. In H. H. Werley, J. J. Fitzpatrick, & R. L. Taunton (Eds.), Annual Review of Nursing Research, 4, 55-75.
46.
Voda, A. M. , Mansfield, P., & Richter, K. (1993, June). Patterns of menstrual bleeding in premenopausal women. Paper presented at the meeting of the Society for Menstrual Cycle Research, Boston, MA.
47.
Wilson, R. (1966). Feminine forever. New York: M. Evans.
48.
Ziel, H. K. , & Finkle, W. D. (1975). Increased risk of endometrial carcinoma among users of conjugated estrogens. New England Journal of Medicine, 293, 1167-1170.
